Delivery Order SPE2DB22D2007-SPE2DB24FJ5CZ
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,038.20 firm-fixed-price delivery order is for the supply of Qsymia 7.5 mg-46 mg capsules. The order has an ultimate completion date of August 12, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,889.56 firm-fixed-price delivery order is for the supply of QSYMIA 15 MG-92 MG capsules. The contract has an ultimate completion date of February 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Qsymia 15 mg-92 mg capsules. The $1,207.32 Firm Fixed Price Delivery Order contract has a completion date of July 22, 2024 and does not have a set-aside designation. As a key vendor for the DLA Troop Support Medical, AmerisourceBergen provides a wide range of pharmaceutical and medical supplies to support various government...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,125.52 Firm Fixed Price delivery order contract is for the supply of QSYMIA 7.5 MG-46 MG capsules. The contract has an ultimate completion date of October 23, 2024 and was not set aside for any specific business types. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of the Amerisourcebergen Corporation. The $4,264.02 firm fixed price delivery order is for the supply of the pharmaceutical product Qsymia 3.75 mg-23 mg capsules. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,078.28 firm fixed-price delivery order is for the supply of QSYMIA 11.25 MG-69 MG capsules. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,077.12 Firm Fixed Price delivery order is for the supply of QSYMIA 11.25 MG-69 MG capsules. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies to provide a wide range of medical commodities, including prescription drugs, medical supplies, and equipment. These...
This federal contract award, valued at $2,997.12, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Qsymia 3.75 MG-23 MG capsules, a prescription medication, to the government. Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, holds several indefinite delivery contracts (IDCs) with federal agencies,...
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB24FXA05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,180.33 firm-fixed-price delivery order is for the supply of QSYMIA 3.75 MG-23 MG capsules, a pharmaceutical product. The contract has an ultimate completion date of September 19, 2024. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded multiple indefinite delivery...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of the pharmaceutical product Qsymia 11.25 mg-69 mg capsules. The contract, valued at $2,228.40, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a firm fixed price pricing type. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure...